AgingResearch.News
Journal of Alzheimer's Disease

Melatonin as a potential biomarker for subclinical epileptiform activity in Alzheimer's disease: An exploratory study

By Amber Nous, Laura Seynaeve, Odile Feys, Show 15 more authorsSebastiaan Engelborghs
Study in peopleBiomarkers
Paper

The paper

Amber Nous, Laura Seynaeve, Odile Feys, Show 15 more authorsSebastiaan Engelborghs

Vrije Universiteit Brussel

Journal of Alzheimer's Disease, 8 Oct 2026

doi.org/10.1177/13872877261490539PubMed 42847306

Related